Delivery Order SPE2DB22D1002-SPE2DB24FLAQ6
- Not listed
- This federal contract award is a delivery order valued at $4,817.16 awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The contract is for the supply of JATENZO 237 MG CAPSULE 120S, a medical product, with a completion date of December 18, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for providing a...
- This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of JATENZO 237 MG CAPSULE 120S, a medical product. The $2,369.45 firm fixed-price delivery order has an ultimate completion date of December 17, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026, which serves as the primary...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of JATENZO 237 MG CAPSULE 120S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,263.07 and a completion date of July 5, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, with a focus on serving the Department of Defense (DoD) and Veterans Affairs (VA)...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,824.07 firm fixed-price delivery order is for the supply of JATENZO 237 MG CAPSULE 120S, a prescription medication. The contract has an ultimate completion date of February 20, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,263.74 firm fixed-price delivery order is for 120 units of the medication JATENZO 237 MG CAPSULE. The contract has an ultimate completion date of January 14, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of JATENZO 237 MG CAPSULE 120S, a pharmaceutical product. The contract has a ceiling value of $1,225.49 and is a firm fixed-price delivery order with a completion date of December 26, 2023. The contract is not designated as a set-aside. Amerisourcebergen holds a...
- This is a Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,317.93, is for the delivery of JATENZO 237 MG CAPSULE 120S, a pharmaceutical product. The contract has an ultimate completion date of June 18, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
- This is a $2,188.14 firm fixed-price delivery order award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the medical product "JATENZO 237 MG CAPSULE 120S" and has a completion date of November 15, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide JATENZO 237 MG CAPSULE 120S. The order has a potential value of $1,263.07 and a period of performance through February 27, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor and is not subject to any set-aside designation on this contract. This award is issued under an...
- This is a firm fixed price delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical. The order is for the pharmaceutical product JATENZO 158 MG CAPSULE 120S, with a ceiling value of $1,094.06 and an ultimate completion date of September 27, 2024. This delivery order is not associated with a set-aside program. As a major pharmaceutical distributor, Amerisourcebergen has numerous Indefinite Delivery Contracts (IDCs) with the DLA and other...
- SPE2DB22D1002Indefinite Delivery Contract
- SPE2DB22D1002-SPE2DB24FLAQ6Delivery Order
The U.S. Defense Logistics Agency (DLA) has awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a delivery order contract valued at $2,703.38 for the supply of 4,564,259,813 units of the pharmaceutical product JATENZO 237 MG CAPSULE 120S. The contract has a firm fixed price pricing type and an ultimate completion date of April 15, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to provide pharmaceuticals and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This contract award does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 4/12/24 |